EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimalarial Drug Mefloquine Strongly Inhibits PI3K (Phosphoinositide 3-kinase) and Exerts Anticancer Activity: A Literature based In Silico Study

Md. Sakib Al Hasan, Md Shimul Bhuia, Tanzila Akter Eity, Salehin Sheikh, Emon Mia, Sajal Roy, Noshin Tasnim Yana

Journal of Medicinal Chemistry and Therapeutics · 2025

DOI: 10.71193/jmct.20250004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry and Therapeutics, 2025. Verfasst von Md. Sakib Al Hasan und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mefloquine (MFQ) is an effective medication for the prevention and treatment of malaria. However, it has anticancer effects found in the literature. The main focus of this study is to review the anticancer activity of MFQ and also find the macromolecules or receptors that are mainly responsible for anticancer activity. For this reason, data was gathered (as of June 30, 2024) by utilizing a variety of reliable and well-known search engines. The molecular docking of MFQ with the selected macromolecules was performed. Our study findings showed that MFQ strongly showed anticancer activity by inhibiting proliferation, tumor growth, mitochondrial respiration, PI3K, MMP, IKK activation, Bcl-2, MCl-1, XIAP, and induced cell death, apoptosis, ROS, and PARP. In addition, an in silico study demonstrated that MFQ showed the highest binding affinity (–8.7 kcal/mol) against PI3K, whereas co-crystal ligand exhibited –8.6 kcal/mol binding affinity. The study also predicted that MFQ has better pharmacokinetics and toxicity parameters. However, we recommend additional evaluation and clinical research to further explore MFQ as a reliable PI3K inhibitor and an anticancer agent.

Zitieren

APA

Hasan, M. S. A., Bhuia, M. S., Eity, T. A., Sheikh, S., Mia, E., Roy, S., & Yana, N. T. (2025). Antimalarial Drug Mefloquine Strongly Inhibits PI3K (Phosphoinositide 3-kinase) and Exerts Anticancer Activity: A Literature based In Silico Study. Journal of Medicinal Chemistry and Therapeutics. https://doi.org/10.71193/jmct.20250004

Vancouver

Hasan MSA, Bhuia MS, Eity TA, Sheikh S, Mia E, Roy S, et al. Antimalarial Drug Mefloquine Strongly Inhibits PI3K (Phosphoinositide 3-kinase) and Exerts Anticancer Activity: A Literature based In Silico Study. Journal of Medicinal Chemistry and Therapeutics. 2025. doi:10.71193/jmct.20250004

BibTeX
@article{Hasan2025,
  author = {Hasan, Md. Sakib Al and Bhuia, Md Shimul and Eity, Tanzila Akter and Sheikh, Salehin and Mia, Emon and Roy, Sajal and Yana, Noshin Tasnim},
  title = {Antimalarial Drug Mefloquine Strongly Inhibits PI3K (Phosphoinositide 3-kinase) and Exerts Anticancer Activity: A Literature based In Silico Study},
  journal = {Journal of Medicinal Chemistry and Therapeutics},
  year = {2025},
  doi = {10.71193/jmct.20250004}
}
Kostenlos starten →